文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

使用VOSviewer和CiteSpace可视化工具对2004年至2024年期间发表的关于肠道菌群与原发性胆汁性胆管炎的研究进行文献计量分析。

Bibliometric analysis of research on intestinal flora and primary biliary cholangitis published between 2004 and 2024 using VOSviewer and CiteSpace visualization.

作者信息

Li Tao, Jing Wang

机构信息

Graduate School of Baotou Medical College, Baotou, China.

Department of Gastroenterology, The Second Affiliated Hospital of Baotou Medical College, Baotou, China.

出版信息

Front Med (Lausanne). 2025 May 21;12:1565778. doi: 10.3389/fmed.2025.1565778. eCollection 2025.


DOI:10.3389/fmed.2025.1565778
PMID:40470048
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12133886/
Abstract

BACKGROUND: Increasing evidence suggests that the onset and progression of primary biliary cholangitis (PBC) are closely linked to changes in gut microbiota, including bacterial translocation, molecular mimicry, and immune regulation. This study aimed to conduct a bibliometric analysis of the frontiers and hotspots of research on the relationship between gut microbiota and PBC between 2004 and 2024. METHODS: A bibliometric study was conducted by searching the Web of Science database for articles on intestinal flora and PBC published between 2004 and 2024. Excel, VOSviewer, and CiteSpace were used for econometric analysis and visualization of the identified articles. RESULTS: Between 2004 and 2024, 167 articles focusing on intestinal flora and PBC were published. The number of publications in this field maintained an upward trend over the years, with China and the United States contributing the highest number of articles. The United States had the highest total number of citations, and the institution with the most publications in the United States was the University of California Davis, with the team led by Professor Gershwin contributing the greatest number of articles. had the highest number of articles in the field, while had the highest impact in terms of publications in this area of research. The main keywords were "primary sclerosing cholangitis," "bile acids," "ursodeoxycholic acid," "cirrhosis," "farnesoid X receptor," "inflammatory bowel disease," "risk factors," and "liver disease." CONCLUSION: There is a correlation between gut microbiota and PBC, and the role of gut microbiota in the pathogenesis and treatment of PBC will continue to be a future research direction. Targets such as bile acids and farnesoid X receptors are also current research hotspots.

摘要

背景:越来越多的证据表明,原发性胆汁性胆管炎(PBC)的发病和进展与肠道微生物群的变化密切相关,包括细菌易位、分子模拟和免疫调节。本研究旨在对2004年至2024年间肠道微生物群与PBC关系的研究前沿和热点进行文献计量分析。 方法:通过检索Web of Science数据库,对2004年至2024年间发表的关于肠道菌群与PBC的文章进行文献计量研究。使用Excel、VOSviewer和CiteSpace对检索到的文章进行计量分析和可视化。 结果:2004年至2024年间,共发表了167篇关注肠道菌群与PBC的文章。该领域的发文数量多年来呈上升趋势,中国和美国的发文数量最多。美国的总被引次数最高,美国发文量最多的机构是加利福尼亚大学戴维斯分校,由Gershwin教授领导的团队发文数量最多。在该领域的文章数量最多,而在该研究领域的出版物影响力方面最高。主要关键词有“原发性硬化性胆管炎”“胆汁酸”“熊去氧胆酸”“肝硬化”“法尼酯X受体”“炎症性肠病”“危险因素”和“肝病”。 结论:肠道微生物群与PBC之间存在相关性,肠道微生物群在PBC发病机制和治疗中的作用将继续成为未来的研究方向。胆汁酸和法尼酯X受体等靶点也是当前的研究热点。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/949e/12133886/97925cbbe268/fmed-12-1565778-g0013.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/949e/12133886/8fa29f420f53/fmed-12-1565778-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/949e/12133886/35fe42167a74/fmed-12-1565778-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/949e/12133886/09ac5c8db890/fmed-12-1565778-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/949e/12133886/b11401b28a7e/fmed-12-1565778-g0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/949e/12133886/15983e5b5c3b/fmed-12-1565778-g0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/949e/12133886/8ab50e6f7cc6/fmed-12-1565778-g0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/949e/12133886/bdd6ac51590c/fmed-12-1565778-g0007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/949e/12133886/5832a7c16312/fmed-12-1565778-g0008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/949e/12133886/2fc12296d152/fmed-12-1565778-g0009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/949e/12133886/8d131111b39d/fmed-12-1565778-g0010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/949e/12133886/5cf169219de4/fmed-12-1565778-g0011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/949e/12133886/17049bc2467d/fmed-12-1565778-g0012.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/949e/12133886/97925cbbe268/fmed-12-1565778-g0013.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/949e/12133886/8fa29f420f53/fmed-12-1565778-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/949e/12133886/35fe42167a74/fmed-12-1565778-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/949e/12133886/09ac5c8db890/fmed-12-1565778-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/949e/12133886/b11401b28a7e/fmed-12-1565778-g0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/949e/12133886/15983e5b5c3b/fmed-12-1565778-g0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/949e/12133886/8ab50e6f7cc6/fmed-12-1565778-g0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/949e/12133886/bdd6ac51590c/fmed-12-1565778-g0007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/949e/12133886/5832a7c16312/fmed-12-1565778-g0008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/949e/12133886/2fc12296d152/fmed-12-1565778-g0009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/949e/12133886/8d131111b39d/fmed-12-1565778-g0010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/949e/12133886/5cf169219de4/fmed-12-1565778-g0011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/949e/12133886/17049bc2467d/fmed-12-1565778-g0012.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/949e/12133886/97925cbbe268/fmed-12-1565778-g0013.jpg

相似文献

[1]
Bibliometric analysis of research on intestinal flora and primary biliary cholangitis published between 2004 and 2024 using VOSviewer and CiteSpace visualization.

Front Med (Lausanne). 2025-5-21

[2]
Correlation between gut microbiota and tumor immune microenvironment: A bibliometric and visualized study.

World J Clin Oncol. 2025-2-24

[3]
Comprehensive bibliometric and visualized analysis of research on gut-liver axis published from 1998 to 2022.

Heliyon. 2024-3-8

[4]
Association between inflammatory bowel disease and primary sclerosing cholangitis: Insights from bibliometric analysis.

Medicine (Baltimore). 2024-5-24

[5]
Bibliometric and visual analysis of intestinal flora and immunity.

Medicine (Baltimore). 2024-1-26

[6]
Emerging trends and hotspots in the links between the bile acids and NAFLD from 2002 to 2022: A bibliometric analysis.

Endocrinol Diabetes Metab. 2024-1

[7]
Mendelian randomization as a cornerstone of causal inference for gut microbiota and related diseases from the perspective of bibliometrics.

Medicine (Baltimore). 2024-6-28

[8]
Global research trends and focus on the link between colorectal cancer and gut flora: a bibliometric analysis from 2001 to 2021.

Front Microbiol. 2023-5-5

[9]
Bibliometric analysis of the intestinal microbiota and demyelinating diseases, particularly multiple sclerosis, since 2014.

Front Neurosci. 2025-3-5

[10]
Immunological factors in cirrhosis diseases from a bibliometric point of view.

World J Gastroenterol. 2023-6-28

本文引用的文献

[1]
Global research trends on gut microbiota and metabolic dysfunction-associated steatohepatitis: Insights from bibliometric and scientometric analysis.

Front Pharmacol. 2024-7-11

[2]
Visual trends and hot research on the relationship between intestinal microbiota and major lipids: a bibliometric analysis.

Front Microbiol. 2024-4-30

[3]
Exploring Advanced Therapies for Primary Biliary Cholangitis: Insights from the Gut Microbiota-Bile Acid-Immunity Network.

Int J Mol Sci. 2024-4-13

[4]
Immunopathogenesis of Primary Biliary Cholangitis, Primary Sclerosing Cholangitis and Autoimmune Hepatitis: Themes and Concepts.

Gastroenterology. 2024-6

[5]
Causal effects from inflammatory bowel disease on liver function and disease: a two-sample Mendelian randomization study.

Front Med (Lausanne). 2024-1-17

[6]
Worldwide research trends on tumor burden and immunotherapy: a bibliometric analysis.

Int J Surg. 2024-3-1

[7]
Autoimmune Markers in Primary Biliary Cholangitis.

Clin Liver Dis. 2024-2

[8]
Integrative bioinformatics analysis and experimental validation of key biomarkers for risk stratification in primary biliary cholangitis.

Arthritis Res Ther. 2023-10-2

[9]
A method for analyzing text using VOSviewer.

MethodsX. 2023-8-22

[10]
Immunological factors in cirrhosis diseases from a bibliometric point of view.

World J Gastroenterol. 2023-6-28

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索